IDEXX Laboratories Basic EPS 2010-2025 | IDXX
IDEXX Laboratories annual/quarterly basic eps history and growth rate from 2010 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- IDEXX Laboratories basic eps for the quarter ending March 31, 2025 was $2.98, a 4.93% increase year-over-year.
- IDEXX Laboratories basic eps for the twelve months ending March 31, 2025 was $10.91, a 4.6% increase year-over-year.
- IDEXX Laboratories annual basic eps for 2024 was $0.011B, a 5.9% increase from 2023.
- IDEXX Laboratories annual basic eps for 2023 was $0.01B, a 25.25% increase from 2022.
- IDEXX Laboratories annual basic eps for 2022 was $0.008B, a 7.09% decline from 2021.
| IDEXX Laboratories Annual Basic EPS | |
|---|---|
| 2024 | $10.77 |
| 2023 | $10.17 |
| 2022 | $8.12 |
| 2021 | $8.74 |
| 2020 | $6.82 |
| 2019 | $4.97 |
| 2018 | $4.34 |
| 2017 | $3.00 |
| 2016 | $2.47 |
| 2015 | $2.07 |
| 2014 | $1.82 |
| 2013 | $1.77 |
| 2012 | $1.62 |
| 2011 | $1.43 |
| 2010 | $1.23 |
| 2009 | $1.04 |
| IDEXX Laboratories Quarterly Basic EPS | |
|---|---|
| 2025-03-31 | $2.98 |
| 2024-12-31 | $2.64 |
| 2024-09-30 | $2.83 |
| 2024-06-30 | $2.46 |
| 2024-03-31 | $2.84 |
| 2023-12-31 | $2.34 |
| 2023-09-30 | $2.55 |
| 2023-06-30 | $2.70 |
| 2023-03-31 | $2.58 |
| 2022-12-31 | $2.08 |
| 2022-09-30 | $2.17 |
| 2022-06-30 | $1.57 |
| 2022-03-31 | $2.30 |
| 2021-12-31 | $1.92 |
| 2021-09-30 | $2.06 |
| 2021-06-30 | $2.37 |
| 2021-03-31 | $2.39 |
| 2020-12-31 | $2.05 |
| 2020-09-30 | $1.71 |
| 2020-06-30 | $1.75 |
| 2020-03-31 | $1.31 |
| 2019-12-31 | $1.06 |
| 2019-09-30 | $1.26 |
| 2019-06-30 | $1.46 |
| 2019-03-31 | $1.19 |
| 2018-12-31 | $1.00 |
| 2018-09-30 | $1.07 |
| 2018-06-30 | $1.25 |
| 2018-03-31 | $1.02 |
| 2017-12-31 | $0.44 |
| 2017-09-30 | $0.81 |
| 2017-06-30 | $0.97 |
| 2017-03-31 | $0.78 |
| 2016-12-31 | $0.58 |
| 2016-09-30 | $0.63 |
| 2016-06-30 | $0.75 |
| 2016-03-31 | $0.51 |
| 2015-12-31 | $0.49 |
| 2015-09-30 | $0.48 |
| 2015-06-30 | $0.61 |
| 2015-03-31 | $0.49 |
| 2014-12-31 | $0.29 |
| 2014-09-30 | $0.52 |
| 2014-06-30 | $0.56 |
| 2014-03-31 | $0.45 |
| 2013-12-31 | $0.42 |
| 2013-09-30 | $0.44 |
| 2013-06-30 | $0.51 |
| 2013-03-31 | $0.41 |
| 2012-12-31 | $0.40 |
| 2012-09-30 | $0.39 |
| 2012-06-30 | $0.47 |
| 2012-03-31 | $0.37 |
| 2011-12-31 | $0.34 |
| 2011-09-30 | $0.34 |
| 2011-06-30 | $0.43 |
| 2011-03-31 | $0.32 |
| 2010-12-31 | $0.32 |
| 2010-09-30 | $0.30 |
| 2010-06-30 | $0.32 |
| 2010-03-31 | $0.29 |
| 2009-12-31 | $0.27 |
| 2009-09-30 | $0.27 |
| 2009-06-30 | $0.29 |
| 2009-03-31 | $0.22 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $43.646B | $3.898B |
| IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $193.761B | 84.87 |
| Thermo Fisher Scientific (TMO) | United States | $161.477B | 19.53 |
| Edwards Lifesciences (EW) | United States | $45.180B | 29.62 |
| Alcon (ALC) | Switzerland | $44.047B | 29.77 |
| DexCom (DXCM) | United States | $32.772B | 50.65 |
| IQVIA Holdings (IQV) | United States | $28.484B | 15.95 |
| Mettler-Toledo (MTD) | United States | $25.057B | 29.80 |
| STERIS (STE) | Ireland | $23.437B | 25.81 |
| Waters (WAT) | United States | $20.942B | 29.55 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.918B | 0.00 |
| Hologic (HOLX) | United States | $14.552B | 15.81 |
| Sysmex ADR (SSMXY) | Japan | $10.948B | 31.06 |
| Penumbra (PEN) | United States | $9.671B | 75.91 |
| Masimo (MASI) | United States | $9.290B | 34.27 |
| Globus Medical (GMED) | United States | $8.200B | 19.54 |
| Glaukos (GKOS) | United States | $5.921B | 0.00 |
| Teleflex (TFX) | United States | $5.373B | 8.87 |
| TransMedics (TMDX) | United States | $4.319B | 93.89 |
| Integer Holdings (ITGR) | United States | $4.229B | 22.16 |
| PROCEPT BioRobotics (PRCT) | United States | $3.219B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.513B | 14.96 |
| Veracyte (VCYT) | United States | $2.160B | 30.31 |
| Nihon Kohden (NHNKY) | Japan | $2.019B | 23.16 |
| Elekta AB (EKTAY) | Sweden | $1.983B | 17.83 |
| Alphatec Holdings (ATEC) | United States | $1.602B | 0.00 |
| Artivion (AORT) | United States | $1.317B | 123.40 |
| Tandem Diabetes Care (TNDM) | United States | $1.138B | 0.00 |
| OPKO Health (OPK) | United States | $1.063B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.051B | 5.59 |
| Pulse Biosciences (PLSE) | United States | $1.031B | 0.00 |
| SiBone (SIBN) | United States | $0.785B | 0.00 |
| IRadimed (IRMD) | United States | $0.782B | 39.70 |
| Beta Bionics (BBNX) | United States | $0.613B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 8.91 |
| Mesa Laboratories (MLAB) | United States | $0.549B | 12.87 |
| OrthoPediatrics (KIDS) | United States | $0.538B | 0.00 |
| RxSight (RXST) | United States | $0.534B | 0.00 |
| AxoGen (AXGN) | United States | $0.504B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.447B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.441B | 11.73 |
| Delcath Systems (DCTH) | United States | $0.436B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.433B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.383B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.381B | 0.00 |
| NeuroPace (NPCE) | United States | $0.342B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.316B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.269B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.263B | 0.00 |
| 908 Devices (MASS) | United States | $0.237B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.236B | 14.27 |
| Neuronetics (STIM) | United States | $0.225B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.215B | 0.00 |
| Inogen (INGN) | United States | $0.200B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.172B | 0.00 |
| CVRx (CVRX) | United States | $0.168B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Accuray (ARAY) | United States | $0.143B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.134B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.114B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.108B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 47.00 |
| EnVVeno Medical (NVNO) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | United States | $0.068B | 0.00 |
| Spectral AI (MDAI) | United States | $0.064B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.059B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.026B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.18 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |